Home Healthcare Healthcare Services Drug Discovery Market

Drug Discovery Market Size, Share & Trends Analysis Report By Drug Type (Small Molecule Drugs, Biologic Drugs), By Technology (High-Throughput Screening (HTS), Bioinformatics & In-Silico Modelling, Computational Drug Discovery & Drug Design, Nanotechnology, Others), By End-user (Pharmaceutical Companies, Contract Research Organizations, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 02, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Drug Discovery Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Small Molecule Drugs
    2. Biologic Drugs
  2. Drug Discovery Market, By Technology  2022-2034 (USD MILLION/ Units)
    1. High-Throughput Screening (HTS)
    2. Bioinformatics & In-Silico Modelling
    3. Computational Drug Discovery & Drug Design
    4. Nanotechnology
    5. Others
  3. Drug Discovery Market, By End-user 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical Companies
    2. Contract Research Organizations
    3. Others
  4. Regional Drug Discovery Market
    1. North America
      1. North America Drug Discovery Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule Drugs
        2. Biologic Drugs
      2. North America Drug Discovery Market By Technology  2022-2034 (USD MILLION/ Units)
        1. High-Throughput Screening (HTS)
        2. Bioinformatics & In-Silico Modelling
        3. Computational Drug Discovery & Drug Design
        4. Nanotechnology
        5. Others
      3. North America Drug Discovery Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Contract Research Organizations
        3. Others
      4. U.S.
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      5. Canada
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
    2. Europe
      1. Europe Drug Discovery Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule Drugs
        2. Biologic Drugs
      2. Europe Drug Discovery Market By Technology  2022-2034 (USD MILLION/ Units)
        1. High-Throughput Screening (HTS)
        2. Bioinformatics & In-Silico Modelling
        3. Computational Drug Discovery & Drug Design
        4. Nanotechnology
        5. Others
      3. Europe Drug Discovery Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Contract Research Organizations
        3. Others
      4. U.K.
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      5. Germany
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      6. France
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      7. Spain
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      8. Italy
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      9. Russia
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      10. Nordic
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      11. Benelux
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      12. Rest of Europe
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
    3. APAC
      1. APAC Drug Discovery Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule Drugs
        2. Biologic Drugs
      2. APAC Drug Discovery Market By Technology  2022-2034 (USD MILLION/ Units)
        1. High-Throughput Screening (HTS)
        2. Bioinformatics & In-Silico Modelling
        3. Computational Drug Discovery & Drug Design
        4. Nanotechnology
        5. Others
      3. APAC Drug Discovery Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Contract Research Organizations
        3. Others
      4. China
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      5. Korea
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      6. Japan
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      7. India
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      8. Australia
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      9. Taiwan
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      10. South East Asia
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      11. Rest of Asia-Pacific
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Drug Discovery Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule Drugs
        2. Biologic Drugs
      2. Middle East and Africa Drug Discovery Market By Technology  2022-2034 (USD MILLION/ Units)
        1. High-Throughput Screening (HTS)
        2. Bioinformatics & In-Silico Modelling
        3. Computational Drug Discovery & Drug Design
        4. Nanotechnology
        5. Others
      3. Middle East and Africa Drug Discovery Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Contract Research Organizations
        3. Others
      4. UAE
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      5. Turkey
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      6. Saudi Arabia
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      7. South Africa
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      8. Egypt
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      9. Nigeria
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      10. Rest of MEA
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
    5. LATAM
      1. LATAM Drug Discovery Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule Drugs
        2. Biologic Drugs
      2. LATAM Drug Discovery Market By Technology  2022-2034 (USD MILLION/ Units)
        1. High-Throughput Screening (HTS)
        2. Bioinformatics & In-Silico Modelling
        3. Computational Drug Discovery & Drug Design
        4. Nanotechnology
        5. Others
      3. LATAM Drug Discovery Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical Companies
        2. Contract Research Organizations
        3. Others
      4. Brazil
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      5. Mexico
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      6. Argentina
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      7. Chile
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      8. Colombia
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
      9. Rest of LATAM
        1. Small Molecule Drugs
        2. Biologic Drugs
        3. High-Throughput Screening (HTS)
        4. Bioinformatics & In-Silico Modelling
        5. Computational Drug Discovery & Drug Design
        6. Nanotechnology
        7. Others
        8. Pharmaceutical Companies
        9. Contract Research Organizations
        10. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.